Sign In
Buy IIIV
$19.61
-0.490 (-2.44%)
At Close: Jun 03, 2026
i3 Verticals to Participate in June 2026 Investor Conferences
04:05pm, Tuesday, 02'nd Jun 2026
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $IIIV--i3 Verticals, Inc. (“i3 Verticals” or the “Company”) (NASDAQ: IIIV), announced today that management plans to participate in two upcoming investor
i3 Verticals Q2 Earnings Call Highlights
04:05pm, Friday, 08'th May 2026
i3 Verticals NASDAQ: IIIV reported second-quarter fiscal 2026 results marked by higher recurring revenue and continued investment in product capabilities, while ongoing weakness in professional servic
i3 Verticals, Inc. (IIIV) Q2 2026 Earnings Call Transcript
03:41pm, Friday, 08'th May 2026
i3 Verticals, Inc. (IIIV) Q2 2026 Earnings Call Transcript
i3 Verticals Reports Second Quarter 2026 Financial Results
04:38pm, Thursday, 07'th May 2026
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $IIIV--i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”) today reported its financial results for the fiscal second quarter ended March
A Look at i3 Verticals Inc (IIIV) After 5.7% Gain -- GF Value $25.34 vs Price $22.40
07:05pm, Monday, 20'th Apr 2026
On April 20, 2026, i3 Verticals Inc (IIIV) shares rose 5.7% to a current price of $22.40, showing a notable recovery in the short term amidst a 52-week range of
i3 Verticals, Inc. (NASDAQ:IIIV) Given Average Recommendation of “Moderate Buy” by Brokerages
04:43am, Friday, 03'rd Apr 2026
Shares of i3 Verticals, Inc. (NASDAQ: IIIV - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, MarketBeat reports.
Comparing i3 Verticals (NASDAQ:IIIV) & Vertex (NASDAQ:VERX)
01:11am, Monday, 09'th Mar 2026
Vertex (NASDAQ: VERX - Get Free Report) and i3 Verticals (NASDAQ: IIIV - Get Free Report) are both computer and technology companies, but which is the superior business? We will compare the two busine
i3 Verticals, Inc. (IIIV) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
01:12pm, Tuesday, 03'rd Mar 2026
i3 Verticals, Inc. (IIIV) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
i3 Verticals to Participate in February and March 2026 Investor Conferences
04:45pm, Wednesday, 11'th Feb 2026
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $IIIV--i3 Verticals, Inc. (“i3 Verticals” or the “Company”) (NASDAQ: IIIV), announced today that management plans to participate in four upcoming investor
i3 Verticals, Inc. (IIIV) Q1 2026 Earnings Call Transcript
11:24am, Friday, 06'th Feb 2026
i3 Verticals, Inc. (IIIV) Q1 2026 Earnings Call Transcript
i3 Verticals Reports First Quarter 2026 Financial Results
04:15pm, Thursday, 05'th Feb 2026
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $IIIV--i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”) today reported its financial results for the fiscal first quarter ended Decembe
i3 Verticals Announces Earnings Release and Conference Call Date for First Quarter of Fiscal 2026
11:00am, Thursday, 22'nd Jan 2026
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $IIIV--i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”), announced today that it will release its financial results for the first quart
i3 Verticals, Inc. (NASDAQ:IIIV) Receives Consensus Rating of “Moderate Buy” from Brokerages
02:02am, Sunday, 18'th Jan 2026
i3 Verticals, Inc. (NASDAQ: IIIV - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight research firms that are covering the stock, Marketbeat reports. Four equiti
Confluence Investment Management LLC Reduces Holdings in i3 Verticals, Inc. $IIIV
05:14am, Wednesday, 24'th Dec 2025
Confluence Investment Management LLC cut its position in i3 Verticals, Inc. (NASDAQ: IIIV) by 61.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange C
Why i3 Verticals Stock Dropped Today
03:33pm, Tuesday, 18'th Nov 2025
Management has high hopes for i3 Verticals' shift to a primarily software-as-a-service (SaaS) business model. Impatient investors are selling.
